← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1997Last known activity
Apr 12, 2019
Timeline
1980s
- Jan 1, 1988
Department of Health, United Kingdom— Founded
Drugs by trial phase (16 distinct, 12 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Angina, Unstable
- Diphtheria
- Dupuytren Contracture
- Fatigue
- Fibrosis
- Hepatitis
- Hepatitis B
- Hutchinson's Melanotic Freckle
- Lentigo
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Meningococcal Infections
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myelodysplastic Syndromes
- Pneumococcal Infections
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Stroke
- Whooping Cough
Recent trials (12)
- NCT03908164CollaboratorPhase 4Apr 12, 2019
- NCT03180957CollaboratorPhase 2Mar 2, 2016
- NCT02550535CollaboratorPhase 1/Phase 2Sep 1, 2015
- NCT02144454CollaboratorN/AJun 1, 2014
- NCT01896596CollaboratorPhase 4Jul 1, 2013
- NCT02376335CollaboratorPhase 2Oct 1, 2012
- NCT01195480CollaboratorPhase 1/Phase 2May 1, 2012
- NCT01621724CollaboratorPhase 1/Phase 2Apr 1, 2012
- NCT01161888CollaboratorPhase 4Jun 1, 2010
- NCT00775944CollaboratorPhase 4Feb 1, 2009
- NCT00159250CollaboratorPhase 1/Phase 2Oct 1, 2007
- NCT00327418CollaboratorPhase 4Jan 1, 1997
Details
- Founded
- London, GB Jan 1, 1988
- Last known activity
- Apr 12, 2019